These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7222471)
41. Dermatofibroma and dermatofibrosarcoma protuberans: a comparative ultrastructural study. Dominguez-Malagon H; Valdez-Carrillo Mdel C; Cano-Valdez AM Ultrastruct Pathol; 2006; 30(4):283-91. PubMed ID: 16971353 [TBL] [Abstract][Full Text] [Related]
42. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434 [TBL] [Abstract][Full Text] [Related]
43. Collagen Features of Dermatofibrosarcoma Protuberans Skin Base on Multiphoton Microscopy. Wu S; Huang Y; Li Z; Wu H; Li H Technol Cancer Res Treat; 2018 Jan; 17():1533033818796775. PubMed ID: 30213241 [TBL] [Abstract][Full Text] [Related]
44. Dermatofibrosarcoma protuberans with EMa+ cells. Report of a case suggesting perineurial cell differentiation. Zamecnik M; Michal M; Baumruk L; Mukensnabl P Pathol Res Pract; 2002; 198(11):767-74; discussion 775. PubMed ID: 12530581 [TBL] [Abstract][Full Text] [Related]
46. An immunohistochemical study of dermatofibrosarcoma protuberans supports its fibroblastic character and contradicts neuroectodermal or histiocytic components. Lautier R; Wolff HH; Jones RE Am J Dermatopathol; 1990 Feb; 12(1):25-30. PubMed ID: 2316813 [TBL] [Abstract][Full Text] [Related]
47. A cutaneous case of giant cell angiofibroma occurring with dermatofibrosarcoma protuberans and showing bimodal CD34+ fibroblastic and FXIIIa+ histiocytic immunophenotype. Silverman JS; Tamsen A J Cutan Pathol; 1998 May; 25(5):265-70. PubMed ID: 9696292 [TBL] [Abstract][Full Text] [Related]
48. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. A clinicopathologic study of nine cases and a comparison with allied tumors. Ding J; Hashimoto H; Enjoji M Cancer; 1989 Aug; 64(3):721-9. PubMed ID: 2545326 [TBL] [Abstract][Full Text] [Related]
49. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases]. Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553 [TBL] [Abstract][Full Text] [Related]
51. Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans. Takahira T; Oda Y; Tamiya S; Yamamoto H; Kawaguchi K; Kobayashi C; Oda S; Iwamoto Y; Tsuneyoshi M Hum Pathol; 2004 Feb; 35(2):240-5. PubMed ID: 14991543 [TBL] [Abstract][Full Text] [Related]
52. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. Ratner D; Thomas CO; Johnson TM; Sondak VK; Hamilton TA; Nelson BR; Swanson NA; Garcia C; Clark RE; Grande DJ J Am Acad Dermatol; 1997 Oct; 37(4):600-13. PubMed ID: 9344201 [TBL] [Abstract][Full Text] [Related]